38 results
Page 2 of 2
6-K
EX-99.1
9legupx
3 Mar 22
Immunocore Reports Full Year 2021 Financial Results
7:01am
6-K
EX-99.1
8t834u3eofyf63j
26 Jan 22
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
4:29pm
6-K
EX-99.2
zoil5567 0v3af
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.3
uk4p5u8
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.1
9unbfwq wx1wm0
24 Aug 21
Current report (foreign)
4:33pm
6-K
EX-99.2
latjig7r
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.3
yl2jth 6zlxqmc0832
11 Aug 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.3
oo1xztf4i6o3yj1
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
6-K
EX-99.2
rbmr 53gfssl995n
12 May 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:00am
20-F
w3ncc7lzs3lexq268yi0
25 Mar 21
Annual report (foreign)
7:01am
424B4
2lf3z13l
8 Feb 21
Prospectus supplement with pricing info
8:36am
F-1/A
0m44fse8510f
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
xdjm4sz1fqof6av0
1 Feb 21
Registration statement (foreign) (amended)
6:21am
CORRESP
vows2ja
1 Feb 21
Correspondence with SEC
12:00am
UPLOAD
en88 or5k8oa85j
29 Jan 21
Letter from SEC
12:00am
F-1
tr40a1mecxh
15 Jan 21
Registration statement (foreign)
4:57pm
CORRESP
w2o53lw5a 76njd
15 Jan 21
Correspondence with SEC
12:00am